InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| FLA-ST (Standard or Ultrapure) | The NLRP3 inflammasome is released as a particulate danger signal that amplif... | 2014 | Nat Immunol. | Baroja-Mazo A. et al. | DOI: 10.1038/ni.2919 |
| Zymosan | Type III IFNs Are Commonly Induced by Bacteria-Sensing TLRs and Reinforce Epi... | 2017 | J Immunol. | Odendall C. et al. | DOI: 10.4049/jimmunol.1700250 |
| Normocin™ - Antimicrobial Reagent | CpG-based immunotherapy impairs antitumor activity of BRAF inhibitors in a B-... | 2017 | Oncogene. | Huang L. et al. | DOI: 10.1038/onc.2017.35 |
| ODN 2006 (ODN 7909) | Toll-like receptor mediated activation is possibly involved in immunoregulati... | 2017 | PLoS One. | Kiewiet M.B. et al. | DOI: 10.1371/journal.pone.0178191 |
| DNA synthesis inhibitor | Identification of common non-coding variants at 1p22 that are functional for ... | 2017 | Nat Commun. | Liu H. et al. | DOI: 10.1038/ncomms14759 |
| 2'3'-cGAMP | DMXAA causes tumor site-specific vascular disruption in murine non-small cell... | 2014 | PLoS One. | Downey C.M. et al. | DOI: 10.1371/journal.pone.0099988 |
| R848 (Resiquimod) | RNAi Screen and Proteomics Reveal NXF1 as a Novel Regulator of IRF5 Signaling. | 2017 | Sci Rep. | Fu B. et al. | DOI: 10.1038/s41598-017-02857-z |
| CL264 | Activation of the NLRP3 inflammasome by group B streptococci. | 2012 | J Immunol. | Costa A. et al. | DOI: 10.4049/jimmunol.1102543 |
| Human TLR7 Reporter HEK293 Cells (NF-κB) | 2'Fluoro Modification Differentially Modulates the Ability of RNAs to Activat... | 2016 | Nucleic Acid Ther. | Lee Y. et al. | DOI: 10.1186/s13075-016-1159-y |
| Pam3CSK4 VacciGrade™ | Ligand engagement of Toll-like receptors regulates their expression in cortic... | 2015 | J Neuroinflammation. | Marinelli C. et al. | DOI: 10.1186/s12974-015-0458-6 |
| Alhydrogel® adjuvant 2% | Prophylactic Herpes Simplex Virus 2 (HSV-2) Vaccines Adjuvanted with Stable E... | 2017 | J Virol. | Hensel M.T. et al. | DOI: 10.1128/JVI.02257-16 |
| ODN 2395 control | CpG oligonucleotide-mediated co-stimulation of mouse invariant natural killer... | 2017 | Cell Tissue Res. | Kulkarni R.R. et al. | DOI: 10.1007/s00441-017-2631-y |
| Rat IgG2a Control | Silkrose: A novel acidic polysaccharide from the silkmoth that can stimulate ... | 2016 | Carbohydr Polym | Ohta T. et al. | DOI: 10.1016/j.carbpol.2015.09.070 |
| Poly(I:C) HMW | Consecutive inoculations of influenza virus vaccine and poly(I:C) protects mi... | 2017 | Vaccine. | Moriyama M. et al. | DOI: 10.1016/j.vaccine.2017.01.025 |
| THP1-Dual™ Cells | Rabex-5 is a lenalidomide target molecule that negatively regulates TLR-induc... | 2016 | PNAS | Millrine D. et al. | DOI: 10.1073/pnas.1611751113 |
| ODN 1585 - TLR9 ligand | Presensitizing with a Toll-like receptor 3 ligand impairs CD8 T-cell effector... | 2012 | PNAS | Ngoi S.M. et al. | DOI: 10.1073/pnas.1202607109 |
| ISD | MPYS/STING-mediated TNF-α, not type I IFN, is essential for the mucosal adjuv... | 2014 | J Immunol. | Blaauboer S.M. et al. | DOI: 10.4049/jimmunol.1301812 |
| MDP | Blau syndrome-associated Nod2 mutation alters expression of full-length NOD2 ... | 2015 | J Immunol. | Dugan J. et al. | DOI: 10.4049/jimmunol.1402330 |
| TLR 2 | Human Adaptive Immunity Rescues an Inborn Error of Innate Immunity. | 2017 | Cell. | Israel L. et al. | DOI: 10.1016/j.cell.2017.01.039 |
| Rec FLA-ST | Induction of Indoleamine 2, 3-dioxygenase by Pre-treatment with Poly (I: C) M... | 2016 | Immune Netw. | Ryu D.B. et al. | DOI: 10.4110/in.2016.16.6.358 |